Curbstone Financial Management Cut Its Chevron (Cvx) (CVX) Stake; Mannkind (MNKD) Sellers Increased By 1.19% Their Shorts

Chevron Corporation (NYSE:CVX) Logo

Mannkind Corporation (NASDAQ:MNKD) had an increase of 1.19% in short interest. MNKD’s SI was 35.94M shares in April as released by FINRA. Its up 1.19% from 35.52 million shares previously. With 1.48 million avg volume, 24 days are for Mannkind Corporation (NASDAQ:MNKD)’s short sellers to cover MNKD’s short positions. The SI to Mannkind Corporation’s float is 37.98%. The stock decreased 1.16% or $0.02 during the last trading session, reaching $1.7. About 1.20 million shares traded. MannKind Corporation (NASDAQ:MNKD) has risen 37.36% since April 29, 2017 and is uptrending. It has outperformed by 25.81% the S&P500.

Curbstone Financial Management Corp decreased Chevron Corp (Cvx) (CVX) stake by 54.6% reported in 2017Q4 SEC filing. Curbstone Financial Management Corp sold 8,409 shares as Chevron Corp (Cvx) (CVX)’s stock declined 8.26%. The Curbstone Financial Management Corp holds 6,993 shares with $875,000 value, down from 15,402 last quarter. Chevron Corp (Cvx) now has $241.97B valuation. The stock increased 1.93% or $2.4 during the last trading session, reaching $126.62. About 8.84M shares traded or 17.40% up from the average. Chevron Corporation (NYSE:CVX) has risen 7.88% since April 29, 2017 and is uptrending. It has underperformed by 3.67% the S&P500.

Among 7 analysts covering Mannkind (NASDAQ:MNKD), 2 have Buy rating, 4 Sell and 1 Hold. Therefore 29% are positive. Mannkind has $9 highest and $0.05 lowest target. $2.49’s average target is 46.47% above currents $1.7 stock price. Mannkind had 16 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Maxim Group with “Buy” on Friday, August 11. Piper Jaffray maintained MannKind Corporation (NASDAQ:MNKD) rating on Wednesday, January 6. Piper Jaffray has “Underweight” rating and $0.05 target. The firm has “Buy” rating by Maxim Group given on Friday, September 1. Maxim Group downgraded the stock to “Hold” rating in Wednesday, November 1 report. On Monday, November 16 the stock rating was downgraded by Griffin Securities to “Neutral”. H.C. Wainwright maintained the shares of MNKD in report on Wednesday, November 8 with “Buy” rating. The stock of MannKind Corporation (NASDAQ:MNKD) earned “Underperform” rating by RBC Capital Markets on Wednesday, November 4. The firm earned “Buy” rating on Tuesday, October 24 by H.C. Wainwright. Maxim Group downgraded MannKind Corporation (NASDAQ:MNKD) rating on Wednesday, February 28. Maxim Group has “Sell” rating and $1.0 target. The stock has “Underweight” rating by Piper Jaffray on Wednesday, September 9.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. The company has market cap of $249.99 million. The Company’s approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It currently has negative earnings.

Since April 17, 2018, it had 0 insider purchases, and 1 sale for $3.11 million activity. 25,500 shares were sold by Pate R. Hewitt, worth $3.11 million.

Chevron Corporation (NYSE:CVX) Institutional Positions Chart